SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

SPRB is trending due to a significant surge following FDA Breakthrough Therapy Designation for its drug targeting a rare disease, Sanfilippo syndrome type B. The community is discussing the potential for continued gains, a possible short squeeze, and comparing it to other high-flying stocks. Some traders express caution, pointing to the company's financials and the potential for a pullback, while others are excited about the long-term potential.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending after news of a multi-year AI compute deal with OpenAI, including potential stock warrants, fueled bullish sentiment. Community members are discussing the potential impact on market share and revenue, with some analysts raising price targets significantly. The conversation highlights a possible shift in the AI chip landscape and increased competition for Nvidia.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation ($ACHR) is trending amid speculation of a partnership with Tesla ($TSLA) after a teaser video featuring both companies sparked rumors of collaboration within the eVTOL space. The community is actively discussing potential price targets, short squeeze opportunities, and whether this partnership is credible or simply hype. Despite liquidity and strong partnerships, concerns around cash burn and certification risks remain a key talking point.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is trending due to speculation around potential U.S. government investment in its Greenland rare earth project, fueled by a Reuters report, though a White House denial has created volatility. Community members are debating the validity of the reports and the broader implications for the company's future, with some viewing it as a strategic play for U.S. resource independence. The stock's price movement and high trading volume reflect the uncertainty and heightened interest surrounding these developments.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending as it begins trading on the NASDAQ, with community members discussing its potential in the quantum computing space and comparing its valuation to sector peers. Optimism is fueled by a partnership with a Korean payment processor and the company's focus on quantum-secure stablecoin settlements. Despite some volatility and concerns about potential dilution, many see long-term growth potential and undervalued status.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp ($LAES) is trending due to significant premarket hype and discussions around potential breakouts, with community members eyeing targets as high as $10. Conversations highlight the company's upcoming chip launch and its positioning in the quantum computing sector alongside names like $NVDA and $QBTS. Some caution about potential dilution, while others express strong bullish sentiment, anticipating a short squeeze and parabolic continuation.

Siyata Mobile, Inc. engages in the provision of cellular communications systems for enterprise customers. It specializes in connected vehicle products for professional fleets, marketed under the Uniden Cellular and Siyata brands. The firm operates through the following geographical segments: Europe, the Middle East and Africa; Unites States; Canada; and Australia and New Zealand. The company was founded by Marc Seelenfreund on October 15, 1986 and is headquartered in Montreal, Canada.

Siyata Mobile Inc

Siyata Mobile ($SYTA) is trending due to the completion of its merger with Core Gaming, rebranding as Core AI Holdings ($CHAI). The company will undergo a 1-for-4 reverse stock split, leading to community discussion around its potential impact and future valuation. There is speculation regarding a possible squeeze and the influence of major shareholders, with some anticipating significant upward movement.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as traders express excitement around this meme coin, referencing the iconic Rage Guy comics and internet culture. The community is actively discussing its potential for a 'moonshot,' emphasizing its connection to early internet humor and relatable, chaotic energy. Some traders suggest that the coin embodies nostalgia and internet rebellion.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending due to community enthusiasm and repeated mentions across social platforms. Community members are drawing comparisons to Bitcoin, emphasizing Weedcoin's potential, and promoting its unique culture. Some users are alleging coordinated efforts to artificially inflate the token's popularity.

VivoPower International Plc is a sustainable energy solutions company, which engages in the customers with turnkey decarbonization solutions that enable them to achieve net zero carbon status. It operates through the following segments: Critical Power Services, Electric Vehicles, Sustainable Energy Solutions, Solar Development, and Corporate Office. The Critical Power Services segment focuses on the design, supply, installation, and maintenance of critical power, control and distribution systems, including for solar farms. The Electric Vehicles segment delivers electric vehicles for mining and other rugged industrial customers. The Sustainable Energy Solutions segment refers to the design, evaluation, sale, and implementation of renewable energy infrastructure to customers both on a standalone basis and in support of Tembo Electric Vehicles. The Solar Development segment represented by caret comprises of 12 solar projects in the US. The Corporate Office segment includes the company’s corporate functions, which refers to the costs to maintain Nasdaq listing, comply with applicable SEC reporting requirements, and related investor relations. The company was founded by Tser Fah Chin on February 1, 2016 and is headquartered in London, the United Kingdom.

VivoPower International PLC

VVPR is trending as community members discuss the company's recent announcement to acquire Ripple shares, offering exposure to XRP. Some are skeptical of the deal and its potential impact, while others express optimism about the company's strategic move into digital assets. Discussions also involve the company's leadership and past business dealings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Strong Buy Stocks for September 26th

FUTU, LRN, CSW, AEM and ELMD have been added to the Zacks Rank #1 (Strong Buy) List on September 26, 2025.

Electromed, Inc. (ELMD) is a Great Momentum Stock: Should You Buy?

Does Electromed, Inc. (ELMD) have what it takes to be a top stock pick for momentum investors? Let's find out.

Electromed (ELMD) is an Incredible Growth Stock: 3 Reasons Why 

Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Wall Street Analysts Believe Electromed (ELMD) Could Rally 52.14%: Here's is How to Trade

The mean of analysts' price targets for Electromed (ELMD) points to a 52.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

3 Reasons Growth Investors Will Love Electromed (ELMD)

Electromed (ELMD) could produce exceptional returns because of its solid growth attributes.

Electromed (ELMD) Upgraded to Buy: Here's What You Should Know

Electromed (ELMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Does Electromed (ELMD) Have the Potential to Rally 38.6% as Wall Street Analysts Expect?

The mean of analysts' price targets for Electromed (ELMD) points to a 38.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Electromed traded higher after hours on Tuesday as management highlighted hospital market share gains from a “distracted rival”, a strategy they credited with contributing to the company’s 11th straight quarter of year-over-year revenue and profit growth.The stock closed up 2.3% at $20.66 on Tuesday and jumped another 12.6% after hours following its earnings release.The maker of the SmartVest airway clearance system reported record fourth-quarter revenue of $17.4 million, up 17% from last year, as profit rose 21% to $2.2 million, or $0.25 a share.&nbsp;On the earnings call, Electromed detailed growth drivers beyond the headline numbers. Executives said hospitals are proving to be a “gateway” channel as patients introduced to SmartVest in care settings are often discharged with prescriptions for home use.&nbsp;CEO Jim Cunniff added that a major competitor with an “older product” is internally distracted, creating opportunities for market share growth.The company also highlighted strong e-prescribe adoption, with 38% of orders now submitted digitally, resulting in a halving of&nbsp;fulfillment times. A new Salesforce-based CRM integrating sales and reimbursement teams has also been rolled out, earning positive early feedback.&nbsp;Productivity gains continue, with sales&nbsp;representatives averaging $1.06 million each in annual revenue, up from $850,000 three years ago. Expansion to 61 territories is planned for FY26.Electromed is also benefiting from greater awareness of bronchiectasis after Insmed’s new drug launch, which executives said is raising disease visibility without competing on airway clearance.&nbsp;Earlier this month, the U.S. Food and Drug Administration (FDA)&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/insmed-announces-fda-approval-for-drug-to-treat-chronic-lung-disease/chrxJPSRdJk">approved Insmed’s Brinsupri</a>, an oral once-daily treatment, as the first and only FDA-approved therapy for non-cystic fibrosis bronchiectasis (NCFB).&nbsp;The drug is cleared for use in adults and children aged 12 and older.&nbsp;Electromed noted over 31,000 visits to its bronchiectasis campaign site and cited registry data showing 58% of patients meeting criteria for HFCWO therapy remain untreated, a gap it sees as a major market opportunity.On Stocktwits, retail sentiment for Electromed was ‘bullish’ amid ‘high’ message volume.<a href="https://stocktwits.com/symbol/ELMD">Electromed’s stock</a> has declined over 30% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Electromed’s stock (ELMD) has declined over 30% so far in 2025. (Photo credit: Getty Images)

Why Electromed Stock Jumped 12% After-Hours: A Rival’s Weakness And A New Drug Tailwind

The after-hours surge came as management pointed to hospital market share gains from a distracted competitor and rising bronchiectasis awareness following Insmed’s FDA-approved drug launch.

Equity

Workday Set to Report Q2 Results: Will Revenue Growth Boost Earnings?

WDAY readies Q2 results with revenue growth driven by AI-powered solutions and rising demand in HCM and finance.

Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates

Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of +30.31% and +73.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.

Electromed Inc.

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

ELMD
Electromed Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ELMD News

ELMD Electromed Inc.